SCHEMBL7503734

SCHEMBL7503734

NS(=O)(=O)c1ccc(-c2oc(Cc3ccccc3)nc2-c2cccs2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 9/20 0.48
▸ CA1 P00915 8/20 0.48
▸ CA9 Q16790 6/20 0.48
▸ CA12 O43570 4/20 0.48
▸ CA14 Q9ULX7 1/20 0.47
▸ PTGS2 P35354 5/20 0.45
▸ PTGS1 P23219 4/20 0.45
▸ KDM4E B2RXH2 5/20 0.41
▸ CA13 Q8N1Q1 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ TP53 P04637 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ MAOA P21397 1/20 0.40
▸ MAOB P27338 1/20 0.40
▸ PPARG P37231 1/20 0.39
▸ NCOA2 Q15596 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7503097 0.91 CA2 (0.48) CA2CA1CA9CA12CA14
SCHEMBL7505232 0.89 PTGS2 (0.48) PTGS2PTGS1KDM4EALDH1A1MAPT
SCHEMBL7501428 0.85 CA1 (0.55) CA2CA1CA9CA12CA14
SCHEMBL7503191 0.85 CA1 (0.55) CA2CA1CA9CA12CA14
SCHEMBL7500833 0.83 PTGS2 (0.65) CA2CA1CA9CA12CA14
SCHEMBL8556864 0.83 SCN9A (0.40) CA2CA9KDM4EALDH1A1GAA
SCHEMBL7504153 0.81 RXRA (0.53) CA2CA1CA9CA12CA14
SCHEMBL7500801 0.81 RXRA (0.53) CA2CA1CA9CA12CA14
SCHEMBL7505500 0.81 PTGS2 (0.61) CA2CA1CA9CA12CA14
SCHEMBL7501237 0.81 PTGS2 (0.61) CA2CA1CA9CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP claimed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP claimed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO claimed
EP-0699192-B1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-07-24 — — EP disclosed
US-6090834-A ANALGESICS; RHEUMATIC DISORDERS; SKIN DISORDERS; GASTROINTESTINAL DISORDERS G.D. SEARLE & CO. (US) 2000-07-18 — — US disclosed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 — — EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 — — WO disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 — — EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 — — WO disclosed
Send feedback